Trials / Conditions / Diabetic Kidney Disease (DKD)

Diabetic Kidney Disease (DKD)

16 registered clinical trials studyying Diabetic Kidney Disease (DKD) — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD) NCT07434791	Sunnybrook Health Sciences Centre	N/A
Not Yet Recruiting	Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression NCT07270198	Mario Negri Institute for Pharmacological Research	N/A
Recruiting	Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Dia NCT07271186	Regeneron Pharmaceuticals	Phase 2
Not Yet Recruiting	Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure NCT07326631	College of Physicians and Surgeons Pakistan	N/A
Not Yet Recruiting	Mesenchymal Stem Cells for Chronic Kidney Diseases NCT07240987	The First Affiliated Hospital of Air Force Medicial University	Phase 1 / Phase 2
Active Not Recruiting	Rubix LS Diabetic Kidney Disease (DKD) Registry Study NCT07348718	Rubix LS	—
Not Yet Recruiting	YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Diseas NCT07034807	Liu Hongfang	N/A
Not Yet Recruiting	YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Diseas NCT07032116	Liu Hongfang	—
Recruiting	Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease NCT06969807	Chinese PLA General Hospital	Phase 2
Recruiting	Efficacy and Safety Study of Isuzinaxib in Subjects With DKD NCT06962098	Aptabio Therapeutics, Inc.	Phase 2
Not Yet Recruiting	Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease NCT06654921	Capital Medical University	N/A
Completed	Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease NCT06639529	The First Hospital of Jilin University	N/A
Active Not Recruiting	Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease NCT06866158	PT. JES Kasih Nusantara Sejahterah	Phase 1 / Phase 2
Completed	ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETI NCT07177898	Narowal Medical College	N/A
Completed	Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases NCT04689074	Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari	—
Completed	Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Di NCT04419467	CSL Behring	Phase 2